Dashboard
Portfolios
Watchlist
Community
Discover
Screener
Community
/
United Kingdom
/
Pharmaceuticals & Biotech
/
GSK
GSK
GSK
Digital Transformation And Global Demographics Will Fuel Expansion
AN
AnalystHighTarget
Not Invested
Consensus Narrative from 18 Analysts
Published
01 Jun 25
Updated
15 Aug 25
3
Set Fair Value
0
votes
Share
AnalystHighTarget
's Fair Value
UK£23.48
39.3% undervalued
intrinsic discount
15 Aug
UK£14.25
Loading
1Y
-10.9%
7D
1.5%
Author's Valuation
UK£23.5
39.3% undervalued
intrinsic discount
AnalystHighTarget Fair Value
View Valuation
Narrative
Updates
0
Valuator
Company Info
Notes
AnalystHighTarget Fair Value
UK£23.5
39.3% undervalued
intrinsic discount
Future estimation in
3 Years
time period
Past
Future
0
40b
2014
2017
2020
2023
2025
2026
2028
Revenue UK£40.3b
Earnings UK£7.6b
Revenue
Profit Margin
Future PE
Revenue
% p.a.
0
Decrease
Increase
Current revenue growth rate
4.01%
Pharma revenue growth rate
0.58%
Other Inputs & Calculation
Risk Level (Discount Rate)
Our default considers factors like the company's size, volatility, profitablity and country of operation.
Risk Level (Discount Rate)
%
0
Decrease
Increase
Current discount rate
6.82%
Calculation
UK£7.64b
Earnings '28
x
14.75x
PE Ratio '28
=
UK£112.65b
Market Cap '28
UK£112.65b
Market Cap '28
/
3.95b
No. shares '28
=
UK£28.50
Share Price '28
UK£28.50
Share Price '28
Discounted to 2025 @ 6.82% p.a.
=
UK£23.38
Fair Value '25